What is gout—and what are the early warning signs to look out for

New research indicates that a drug commonly prescribed for gout may also lower the risk of heart attack and stroke when taken ...
Healio

Urate-lowering treatment may reduce cardiovascular risk in patients with gout

Patients with gout who achieve a serum urate level lower than 6 mg/dL demonstrated a lower 5-year risk for cardiovascular ...
Yahoo Finance

Sobi completes acquisition of Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout

STOCKHOLM, Feb. 9, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) Sobi® (STO: SOBI) and Arthrosi Therapeutics, Inc. (Arthrosi) announced today the completion of the acquisition of Arthrosi by ...
American Institute of Physics

Designing a simpler way to diagnose gout

Applying a magnetic field to orient the acid crystals in the joints changes their reflectivity, leading to a noninvasive way ...
News Medical

Diabetes drug use linked to fewer gout treatments

Natalie McCormick, PhD, of the Rheumatology and Allergy Clinical Epidemiology Research (RACER) Center within the Division of Rheumatology in the Mass General Brigham Department of Medicine, is the ...

Swedish Orphan Biovitrum AB: Sobi completes acquisition of Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout

Swedish Orphan Biovitrum AB (publ) Sobi (STO: SOBI) and Arthrosi Therapeutics, Inc. (Arthrosi) announced today the completion of the acquisition of Arthrosi ...

Sobi’s Arthrosi Deal Brings Late Stage Gout Asset Into Focus

Swedish Orphan Biovitrum (OM:SOBI) has completed its acquisition of Arthrosi Therapeutics. The deal adds a late stage Phase 3 investigational therapy for gout to Sobi’s portfolio. The transaction ...